Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT02914522 · COMPLETED
Trial details
- NCT number
- NCT02914522
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-14
- Primary completion
- 2020-03-31
- Enrollment
- 1351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.